First, we confirmed elevated urine levels of CCL5, CCL11, CXCL10, BAFF, HGF, 8-izoprostane and oxidized guanine species in IC/BPS patients compared to controls [15–18, 36–38]. The gene discussed is TNFSF13B; the disease is Bartsocas-Papas syndrome 1.